Alpha beta double negative T cells in children with systemic lupus erythematosus: The relation to disease activity and characteristics

References

• Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358(9):39.
   Web of Science ®Google Scholar
• Ramirez GA, Uribe UO, Osio UO, Grisales RH, Cardiel MH, Wojdyla D, et al. Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. Lupus. 2008;17(6):596–604.
   PubMed Web of Science ®Google Scholar
• Adalid-Peralta L, Mathian A, Tran T, Delbos L, Durand-Gasselin I, Berrebi D, et al. Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis. Kidney Int. 2008;73(2):172–80.
   PubMed Web of Science ®Google Scholar
• Liossis NC, Tsokos GC. B-cell abnormalities in systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois’ Lupus Erythematosus. 5th ed. Philadelphia: Williams & Wilkins; 2001. p. 205–18.
   Google Scholar
• Crispin JC, Kyttaris VC, Juang YT, Tsokos GC. How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Trends Immunol. 2008;29(3):110–15.
   PubMed Web of Science ®Google Scholar
• Holler PD, Kranz DM. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity. 2003;18(2):255–64.
   PubMed Web of Science ®Google Scholar
• Treiner E, Lantz O. CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol. 2006;18(5):519–26.
   PubMed Web of Science ®Google Scholar
• Bleesing JJ, Brown MR, Dale JK, Straus SE, Lenardo MJ, Puck JM, et al. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol. 2001;100(3):314–24.
   PubMed Web of Science ®Google Scholar
• Russell TB, Kurre P. Double negative T cells are non ALPS specific markers of immune dysregulation found in patients with aplastic anemia. Blood. 2010;116(23):5072–3.
   PubMed Web of Science ®Google Scholar
• Juvet SC, Zhang L. Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions. J Mol Cell Biol. 2012;4(1):48–58.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Mosca M, Bombardieri S. Assessing remission in systemic lupus erythematosus. Clin Exp Rheumatol. 2006;24(6 Suppl 43):S–104.
   Web of Science ®Google Scholar
• Gladman DD, Ibanez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002;29(2):288–91.
   PubMed Web of Science ®Google Scholar
• Worth A, Thrasher AJ, Gaspar HB. Autoimmune lympho-proliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol. 2006;133(2):124–40.
   PubMed Web of Science ®Google Scholar
• Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521–30.
   PubMed Web of Science ®Google Scholar
• Fagerland MW, Lydersen S, Laake P. The McNemer test for binary matched-pairs data: mid-p and asymptomatic are better than exact conditional. BMC Med Res Methodol. 2013;13:91–5.
   PubMed Web of Science ®Google Scholar
• Hinkle DE, Wiersma W, Jurs SG. Applied Statistics. In: Hinkle DE, Wiersma W, Jurs SG, editors. Applied Statistics for the Behavioral Sciences. 5th ed. Boston: Houghton Mifflin; 2003. p. 40–65.
   Google Scholar
• Anand A, Dean GS, Quereshi K, Isenberg DA, Lydyard P. Characterization of CD3 + CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers. Lupus 2002;11(8):493–500.
   PubMed Web of Science ®Google Scholar
• Dean GS, Anand A, Blofeld A, Isenberg DA, Lydyard PM. Characterization of CD3 + CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4. Lupus 2002;11(8):501–7.
   PubMed Web of Science ®Google Scholar
• Tarbox JA, Keppel MP, Topcagic N, Mackin C, Baszis KW, White AJ, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34(5):594–9.
   PubMed Web of Science ®Google Scholar
• Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest. 2006;98(5):1107–13.
   Google Scholar
• Satoh M, Weintraub JP, Yoshida H, Shaheen VM, Richards HB, Shaw M, et al. Fas and Fas ligand mutation inhibit autoantibody production in pristane induced lupus. J Immunol. 2000;165(2):1036–43.
   PubMed Web of Science ®Google Scholar
• Ford MS, Zhang ZX, Chen W, Zhang L. Double negative T regulatory cells can develop outside the thymus and do not mature from CD8+ T cell precursors. J Immunol. 2006;177(5):2803–9.
   PubMed Web of Science ®Google Scholar
• Koga T, Ichinose K, Mizui M, Crispian JC, Tsokos GC. Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus. J Immunol. 2012;189(7):3490–6.
   PubMed Web of Science ®Google Scholar
• Grishkan IV, Ntranos A, Calabresi PA, Gocke AR. Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells. Cell Immunol. 2013;284(1–2):68–74.
   PubMed Web of Science ®Google Scholar
• Oliveira OB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lympho-proliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116(14):35–40.
   PubMed Web of Science ®Google Scholar
• Teachey DT, Greiner R, Seif A, Attiyeh E, Bleesing J, Choi J, et al. Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome. Br J Haematol. 2009;145(1):101–6.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Abe S, Tsuchida M, Hirahara H, Abo T, Shin T, et al. Characterization of CD4-CD8- T cell receptor αβ + T cells appearing in the subarachnoid space of rats with autoimmune encephalomyelitis. Eur J Immunol. 1996;26(6):1328–34.
   PubMed Web of Science ®Google Scholar
• Dickey BZ, Holland KE, Drolet BA, Galbraith SS, Lyon VB, Siegel DH, et al. Demographic and clinical characteristics of cutaneous lupus erythematosus at a paediatric dermatology referral centre. Br J Dermatol. 2013;169(2):428–33.
   PubMed Web of Science ®Google Scholar
• Livingston B, Bonner A, Pope J. Differences in autoantibody profiles and disease activity and damage scores between childhood and adult-onset systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2012;42(3):271–80.
   PubMed Web of Science ®Google Scholar
• Gokce M, Bilginer Y, Besbas N, Ozaltin F, Cetin M, Gumruk F, et al. Hematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children. Lupus. 2012;21(8):878–84.
   PubMed Web of Science ®Google Scholar
• Screpanti I, Morrone S, Meco D, Santoni A, Gulino A, Paolini R, et al. Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J Immunol. 2009;142(10):3378–83.
   Google Scholar